One Wealth Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

One Wealth Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-286	Closed	-$216K	–	203
2021 Q4	$216K	Buy	+286	New	+$214K	0.05%	185
2019 Q2	–	Sell	-30	Closed	-$9K	–	162
2019 Q1	$9K	Buy	+30	New	+$8.1K	0.01%	322
2018 Q4	–	Sell	-116	Closed	-$36K	–	145
2018 Q3	$36K	Hold	116	–	–	0.03%	282
2018 Q2	$33K	Sell	116 -5	-4%	-$1.38K	0.03%	281
2018 Q1	$30K	Sell	121 -6	-5%	-$1.53K	0.03%	276
2017 Q4	$30K	Buy	+127	New	+$30.8K	0.02%	303

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

One Wealth Advisors's BIO Position: Q1 2022 in Review

One Wealth Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2022, closing a stake of 286 shares — an estimated $216K sold.

One Wealth Advisors first reported a position in BIO in Q4 2017 and held it in 6 quarters. The position peaked at $216K in Q4 2021. 515 funds tracked by Wall St. Rank hold BIO as of Q1 2022.

One Wealth Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q1 2022 after selling out during the quarter.
One Wealth Advisors sold 286 Bio-Rad Laboratories Class A shares in Q1 2022, an estimated $216K.
One Wealth Advisors first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and held it in 6 quarters.
One Wealth Advisors's Bio-Rad Laboratories Class A position peaked at $216K in Q4 2021.
515 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2022.

Based on One Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.